Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications George AndersonMichael BerkMichael Maes Leading Article 23 October 2013 Pages: 1 - 10
Emerging Targets in Migraine Jan HoffmannPeter J. Goadsby Review Article 08 December 2013 Pages: 11 - 17
Continuous Drug Delivery in Parkinson’s Disease Marina SenekDag Nyholm Review Article 10 December 2013 Pages: 19 - 27
The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy Chris RundfeldtWolfgang Löscher Review Article 20 December 2013 Pages: 29 - 43
Drug Repositioning: Playing Dirty to Kill Pain Leandro Francisco Silva BastosMárcio Matos Coelho Review Article 11 December 2013 Pages: 45 - 61
Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone Jia LiuLu-ning Wang Systematic Review 16 November 2013 Pages: 63 - 68
Generic Products of Antiepileptic Drugs: A Perspective on Bioequivalence, Bioavailability, and Formulation Switches Using Monte Carlo Simulations Vangelis KaralisPanos MacherasMeir Bialer Original Research Article 03 October 2013 Pages: 69 - 77
Antidepressant Class, Age, and the Risk of Deliberate Self-Harm: A Propensity Score Matched Cohort Study of SSRI and SNRI Users in the USA Matthew MillerV. PateT. Stürmer Original Research Article 22 October 2013 Pages: 79 - 88